Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma

Matija Snuderl1, Ladan Fazlollahi, Long P Le

  • 1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Cancer Cell
|December 6, 2011
PubMed

Insights

Genetic heterogeneity in brain tumors involves multiple driver genes amplified in adjacent cells. This finding impacts targeted therapy resistance due to coexisting tumor cell subpopulations.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Tumor heterogeneity contributes to cancer progression and therapy resistance.
  • Understanding genetic diversity within tumors is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate genetic heterogeneity in human malignant brain tumors.
  • To identify coexisting, distinct cell subpopulations with amplified driver genes within single tumors.

Main Methods:

  • Analysis of genetic alterations in human malignant brain tumors.
  • Detection of amplified receptor tyrosine kinases (EGFR, MET, PDGFRA) in individual cells.
  • Assessment of cell division and protein production in subpopulations.

Main Results:

  • Observed simultaneous amplification of multiple driver genes (EGFR, MET, PDGFRA) in adjacent, intermingled cells within single tumors.
  • Found that amplifications occurred in a mutually exclusive manner across different cell subpopulations.
  • Confirmed that each subpopulation was actively dividing, produced proteins, and shared common early mutations, indicating a single precursor cell origin.

Conclusions:

  • Malignant brain tumors can exhibit significant genetic heterogeneity with distinct, coexisting clones.
  • Simultaneous amplification of multiple receptor tyrosine kinases in different cells suggests complex evolutionary pathways.
  • This genetic diversity has critical implications for the development of resistance to targeted therapies.